
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
CARM1 CRISPR/Cas9 KO Plasmid (m) | sc-425576 | 20 µg | $397.00 |
Carm1 encodes coactivator-associated arginine methyltransferase 1 (CARM1/PRMT4), a histone and non-histone protein arginine methyltransferase that regulates chromatin accessibility and transcriptional programs. CARM1 methylates substrates such as histone H3 (e.g., H3R17/H3R26) and transcriptional regulators, coordinating RNA polymerase II–dependent gene expression, alternative splicing, and signal-responsive transcription. In mouse cells, Carm1 influences pathways linked to nuclear receptor and growth factor signaling, cell fate decisions, and epigenetic control of differentiation and proliferation. Dysregulated CARM1 activity is widely studied in contexts of aberrant transcriptional regulation, developmental defects, and oncogenic signaling, making it a relevant target for mechanistic studies of epigenetic and transcriptional networks.
CARM1 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Carm1 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Carm1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Carm1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish CARM1 protein expression.
This CRISPR knockout system enables efficient generation of Carm1-deficient cell models for investigation of CARM1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.